7Baggers
 PDS Biotechnology: Q3 Earnings Snapshot  New Haven Register Fri, 14 Nov 2025 07:03:52 GMT
 PDS Biotechnology: Promising Trial Results and Financial Update  TipRanks Fri, 14 Nov 2025 05:28:52 GMT
 earnings call transcript: pds biotech beats eps expectations in q3 2025  Investing.com UK Fri, 14 Nov 2025 00:22:40 GMT
 PDS Biotechnology reports Q3 EPS (19c), consensus (20c)  TipRanks Thu, 13 Nov 2025 18:31:38 GMT
 pds biotechnology q3 2025 earnings report  MarketBeat Thu, 13 Nov 2025 18:07:08 GMT
 Earnings call transcript: PDS Biotech beats EPS expectations in Q3 2025 By Investing.com  Investing.com South Africa Thu, 13 Nov 2025 14:19:54 GMT
 PDS Biotechnology Q3 2025 Earnings Call Transcript  MarketBeat Thu, 13 Nov 2025 14:15:00 GMT
 PDS Biotechnology: Q3 Earnings Snapshot  San Francisco Chronicle Thu, 13 Nov 2025 12:55:39 GMT
 PDS Biotechnology Q3 net loss narrows on lower operating expenses  TradingView Thu, 13 Nov 2025 12:41:00 GMT
 PDS Biotechnology Q3 2025 Earnings Preview  MSN Thu, 13 Nov 2025 02:29:03 GMT
 A Look Ahead: PDS Biotechnology's Earnings Forecast  Benzinga Wed, 12 Nov 2025 17:03:09 GMT
 PDS Biotechnology Faces Investor Backlash Over Equity Offering  AD HOC NEWS Wed, 12 Nov 2025 14:04:04 GMT
 PDS Biotech raises $5.3 million in registered direct offering By Investing.com  Investing.com Nigeria Wed, 12 Nov 2025 08:28:47 GMT
 PDS Biotech raises $5.3 million in registered direct offering  Investing.com India Tue, 11 Nov 2025 20:44:59 GMT
 PDS Biotech reports positive data on cancer immunotherapy mechanisms  Investing.com Tue, 11 Nov 2025 00:39:29 GMT
 PDS Biotechnology Announces Positive Data at Cancer Meeting  TipRanks Mon, 10 Nov 2025 14:01:01 GMT
 pds biotech reports positive data on cancer immunotherapy mechanisms  Investing.com India Mon, 10 Nov 2025 13:47:43 GMT
 pds biotechnology corp announces positive data at sitc 2025  TradingView Mon, 10 Nov 2025 13:45:00 GMT
 PDS Biotechnology Announces Translational Data Showing  GlobeNewswire Mon, 10 Nov 2025 13:30:00 GMT
 Pivotal Week Ahead for PDS Biotechnology Shares  AD HOC NEWS Mon, 03 Nov 2025 12:02:04 GMT
 PDS Biotechnology Seeks Accelerated FDA Pathway for Cancer Therapy  AD HOC NEWS Fri, 31 Oct 2025 07:00:00 GMT
 pds biotech stock soars after seeking expedited approval pathway for cancer drug  Investing.com Australia Thu, 30 Oct 2025 07:00:00 GMT
 PDS Biotechnology Seeks FDA Meeting for PDS0101 Approval  TipRanks Wed, 29 Oct 2025 07:00:00 GMT
 PDS Biotechnology Corp Seeks Expedited FDA Approval for PDS0101  TradingView Wed, 29 Oct 2025 07:00:00 GMT

PDS Biotechnology Corporation
(NASDAQ:PDSB) 

PDSB stock logo

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cance...

Founded: 2005
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends